HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of early enteral nutrition on critical care outcomes in patients with acute ischemic stroke.

AbstractOBJECTIVE:
Stroke-associated pneumonia (SAP) is a comorbidity of ischemic stroke related to clinical outcomes. Early enteral nutrition (EEN; within 48 hours) reduces the incidence of infection and length of intensive care unit (ICU)/hospital stay. The relationship between EEN and critical care outcomes, including SAP, in patients with ischemic stroke has been insufficiently studied.
METHODS:
We recruited 499 patients in this retrospective observational study. We evaluated SAP incidence within 14 days from admission. Patients were divided into an EEN group and a late EN group (LEN; start later than EEN). We compared groups regarding background and length of ICU/hospital stay.
RESULTS:
EN was started within 48 hours in 236 patients. SAP was diagnosed in 94 patients (18.8%), with most in the LEN group (28.1% vs. 8.5%). Median [interquartile range] lengths of hospitalization (22 [12-30] days vs. 35 [20-45] days) and ICU stay (4 [2-5] days vs. 6 [3-8] days) were longer in the LEN group. EEN reduced the incidence of SAP. By contrast, consciousness disturbance and worsening consciousness level increased the SAP incidence. Increased age and National Institutes of Health Stroke Scale score were associated with start of prolonged EN.
CONCLUSIONS:
We found that EEN may reduce SAP risk.
AuthorsAtsushi Mizuma, Shizuka Netsu, Masaki Sakamoto, Sachiko Yutani, Eiichiro Nagata, Shunya Takizawa
JournalThe Journal of international medical research (J Int Med Res) Vol. 49 Issue 11 Pg. 3000605211055829 (Nov 2021) ISSN: 1473-2300 [Electronic] England
PMID34796764 (Publication Type: Journal Article, Observational Study)
Topics
  • Brain Ischemia (therapy)
  • Critical Care Outcomes
  • Enteral Nutrition
  • Humans
  • Intensive Care Units
  • Ischemic Stroke
  • Length of Stay
  • Stroke (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: